-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-01-19
Values as of: 2019-01-19
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index that tracks the performance of publicly traded companies in the insurance industry. In seeking to track the performance of the S&P Insurance Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the insurance segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
Company Website : www.spdrs.com
Currency: USD
Country : USA
Inception Date: 08/11/2005
Primary Benchmark: S&P Insurance Select Industry TR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.35%
Management Expense Ratio: 0.35 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
MTUS | Metallus Inc | 2.29 % |
SDMHF | Sartorius Stedim Biotech S.A | 2.22 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
XLF | Financial Select Sector SPDR®.. | 0.13 % |
+0.55 (+1.38%) |
USD 38.44B |
VFH | Vanguard Financials Index Fund.. | 0.10 % |
+1.35 (+1.40%) |
USD 8.94B |
KRE | SPDR® S&P Regional Banking ET.. | 0.35 % |
+1.21 (+2.62%) |
USD 2.80B |
IYF | iShares U.S. Financials ETF | 0.42 % |
+1.26 (+1.40%) |
USD 2.52B |
KBE | SPDR® S&P Bank ETF | 0.35 % |
+1.01 (+2.33%) |
USD 1.69B |
FNCL | Fidelity® MSCI Financials Ind.. | 0.08 % |
+0.79 (+1.41%) |
USD 1.58B |
IYG | iShares U.S. Financial Service.. | 0.42 % |
+0.76 (+1.21%) |
USD 1.30B |
BIZD | VanEck BDC Income ETF | 0.41 % |
+0.10 (+0.61%) |
USD 0.98B |
FXO | First Trust Financials AlphaDE.. | 0.63 % |
+0.64 (+1.45%) |
USD 0.87B |
IAK | iShares U.S. Insurance ETF | 0.43 % |
+2.25 (+2.03%) |
USD 0.66B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
INAV | 11.54 % | 0.00 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Financial) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 6.80% | 13% | F | 51% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | F | ||
Total Return | 6.80% | 13% | F | 51% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -2.95% | 100% | F | 70% | C- | ||
Dividend Return | 1.21% | 14% | F | 21% | F | ||
Total Return | -1.74% | 91% | A- | 62% | D | ||
Trailing 5 Years | |||||||
Capital Gain | 47.73% | 95% | A | 83% | B | ||
Dividend Return | 10.09% | 40% | F | 34% | F | ||
Total Return | 57.82% | 90% | A- | 81% | B- | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 10.27% | 61% | D- | 80% | B- | ||
Dividend Return | 12.08% | 61% | D- | 80% | B- | ||
Total Return | 1.81% | 48% | F | 37% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 9.34% | 100% | F | 70% | C- | ||
Risk Adjusted Return | 129.35% | 100% | F | 93% | A | ||
Market Capitalization | 0.79B | 65% | D | 50% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The company has under performed its peers on annual average total returns in the past 5 years.